Authors: Ascioglu, S Rex, JH de Pauw, B Bennett, JE Bille, J Crokaert, F Denning, DW Donnelly, JP Edwards, JE Erjavec, Z Fiere, D Lortholary, O Maertens, J Meis, JF Patterson, TF Ritter, J Selleslag, D Shah, PM Stevens, DA Walsh, TJ

Citation: S. Ascioglu et al., Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An internationalconsensus, CLIN INF D, 34(1), 2002, pp. 7-14

Authors: Ellis, M Richardson, M de Pauw, B

Citation: M. Ellis et al., Epidemiology, HOSP MED, 61(9), 2000, pp. 605-609

Authors: de Pauw, B

Citation: B. De Pauw, Is there a need for new antifungal agents?, CL MICRO IN, 6, 2000, pp. 23-28

Authors: Ellis, M Spence, D de Pauw, B Meunier, F Marinus, A Collette, L Sylvester, R Meis, J Boogaerts, M Selleslag, D Kremery, V von Sinner, W MacDonald, P Doyen, C Vandercam, B

Citation: M. Ellis et al., An EORTC international multicenter randomized trial (EORTC number 19923) comparing two dosages of liposomal amphotericin B for treatment of invasive aspergillosis, CLIN INF D, 27(6), 1998, pp. 1406-1412

Authors: Brinkman, K Delnoy, PP de Pauw, B

Citation: K. Brinkman et al., Highly active antiretroviral therapy (HAART) and prolonged survival of a patient with an HIV-related Burkitt lymphoma, despite an intracardiac relapse, INT J STD A, 9(12), 1998, pp. 773-775